Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
10.84
-0.04 (-0.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $488.43 million as of December 20, 2024. Its market cap has increased by 28.19% in one year.
Market Cap
488.43M
Enterprise Value
195.74M
1-Year Change
28.19%
Ranking
Category
Stock Price
$10.84
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $488.43M, a decrease of -25.75%. That is a compound annual growth rate of -12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 488.43M | 10.31% |
| Dec 29, 2023 | 442.78M | 153.97% |
| Dec 30, 2022 | 174.34M | -73.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Talkspace | 503.39M |
| Auna S.A. | 501.16M |
| EyePoint Pharmaceuticals | 498.14M |
| Terns Pharmaceuticals | 497.74M |
| Cartesian Therapeutics | 489.30M |
| Verve Therapeutics | 485.97M |
| MeiraGTx Holdings | 480.64M |
| Alumis | 479.87M |